Yeon Ho Choi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Yeon Ho Choi has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Hyun-Jin Kim
Cancer Big Data Center, National Cancer Control Institute, National Cancer Center, Goyang-si, South Korea
2 shared publications - Juyeon Hwang
National Cancer Control Institute, National Cancer Center, Goyang, South Korea
2 shared publications - Phillip Park
Affiliations Department of Digital Health, Samsung Advanced Institute for Health Sciences and Technology, Sung Kyun Kwan University, Seoul, Korea, Cancer Data Center, National Cancer Control Institute, National Cancer Center, Goyang, Korea
2 shared publications - Ye-Lin Park
Affiliation Cancer Data Center, National Cancer Control Institute, National Cancer Center, Goyang, Korea
2 shared publications - Chong Woo Yoo
Department of Pathology, National Cancer Center, Goyang, Korea
1 shared publication - Dong-Woo Choi
Cancer Data Center, National Cancer Control Institute, National Cancer Center, Goyang 10408, Republic of Korea
1 shared publication
Latest Publications
- Open Access
- 1 January 2026
- Published by XMLink in Journal of Korean Medical Science
- Vol. 41 (8) , e79
Application of a Natural Language Processing Framework for Data Extraction From Pathology Reports Across Multiple Cancer Types
Park P, et al. J Korean Med Sci. 2026 Feb;41:e79. https://doi.org/10.3346/jkms.2026.41.e79
- 1 January 2026
- Published by XMLink in Journal of Korean Medical Science
- Vol. 41 (8) , e79
Open AccessApplication of a Natural Language Processing Framework for Data Extraction From Pathology Reports Across Multiple Cancer Types
Park P, et al. J Korean Med Sci. 2026 Feb;41:e79. https://doi.org/10.3346/jkms.2026.41.e79
- Open Access
Mortality Prediction Modeling for Patients with Breast Cancer Based on Explainable Machine Learning
Background/Objectives: Breast cancer is the most common cancer in women worldwide, requiring strategic efforts to reduce its mortality. This study aimed to develop a predictive classification model for breast cancer mortality using real-world data, including various clinical features. Methods: A total of 11,286 patients with breast cancer from the National Cancer Center were included in this study. The mortality rate of the total sample was approximately 6.2%. Propensity score matching was used to reduce bias. Several machine learning models, including extreme gradient boosting, were applied to 31 clinical features. To enhance model interpretability, we used the SHapley Additive exPlanations method. ML analyses were also performed on the samples, excluding patients who developed other cancers after breast cancer. Results: Among the ML models, the XGB model exhibited the highest discriminatory power, with an area under the curve of 0.8722 and a specificity of 0.9472. Key predictors of the mortality classification model included occurrence in other organs, age at diagnosis, N stage, T stage, curative radiation treatment, and Ki-67(%). Even after excluding patients who developed other cancers after breast cancer, the XGB model remained the best-performing, with an AUC of 0.8518 and a specificity of 0.9766. Additionally, the top predictors from SHAP were similar to the results for the overall sample. Conclusions: Our models provided excellent predictions of breast cancer mortality using real-world data from South Korea. Explainable artificial intelligence, such as SHAP, validated the clinical applicability and interpretability of these models.
Open AccessMortality Prediction Modeling for Patients with Breast Cancer Based on Explainable Machine Learning
Background/Objectives: Breast cancer is the most common cancer in women worldwide, requiring strategic efforts to reduce its mortality. This study aimed to develop a predictive classification model for breast cancer mortality using real-world data, including various clinical features. Methods: A total of 11,286 patients with breast cancer from the National Cancer Center were included in this study. The mortality rate of the total sample was approximately 6.2%. Propensity score matching was used to reduce bias. Several machine learning models, including extreme gradient boosting, were applied to 31 clinical features. To enhance model interpretability, we used the SHapley Additive exPlanations method. ML analyses were also performed on the samples, excluding patients who developed other cancers after breast cancer. Results: Among the ML models, the XGB model exhibited the highest discriminatory power, with an area under the curve of 0.8722 and a specificity of 0.9472. Key predictors of the mortality classification model included occurrence in other organs, age at diagnosis, N stage, T stage, curative radiation treatment, and Ki-67(%). Even after excluding patients who developed other cancers after breast cancer, the XGB model remained the best-performing, with an AUC of 0.8518 and a specificity of 0.9766. Additionally, the top predictors from SHAP were similar to the results for the overall sample. Conclusions: Our models provided excellent predictions of breast cancer mortality using real-world data from South Korea. Explainable artificial intelligence, such as SHAP, validated the clinical applicability and interpretability of these models.